David E. Alonzo
Impact in
- Pharmaceutical Science top 0.1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Analytical Chemistry top 2%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Drug Solubulity and Delivery Systems 10
-
- Crystallization and Solubility Studies 8
- Co-authors
- Lynne S. Taylor (12 shared papers)Yi Gao (8 shared papers)Geoff G. Z. Zhang (8 shared papers)Deliang Zhou (3 shared papers)Shweta A. Raina (6 shared papers)Tetsurou Handa (1 shared paper)Huaping Mo (2 shared papers)Nathaniel D. Catron (2 shared papers)
- Journals
- Pharmaceutical Research (5 papers)Journal of Pharmaceutical Sciences (3 papers)Molecular Pharmaceutics (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Crystal Growth & Design (1 paper)
- Partner nations
- United StatesJapanBelgium
In The Last Decade
David E. Alonzo
13 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 1.5k
- Analytical Chemistry 256
- Spectroscopy 337
- Materials Chemistry 929
- Pharmacology 102
Countries citing papers authored by David E. Alonzo
This map shows the geographic impact of David E. Alonzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Alonzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Alonzo more than expected).
Fields of papers citing papers by David E. Alonzo
This network shows the impact of papers produced by David E. Alonzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Alonzo. The network helps show where David E. Alonzo may publish in the future.
Co-authors
The 14 scholars most cited alongside David E. Alonzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 397 | |
| 2 | 2008 | 331 | |
| 3 | 2011 | 236 | |
| 4 | 2009 | 165 | |
| 5 | 2013 | 162 | |
| 6 | 2012 | 127 | |
| 7 | 2015 | 116 | |
| 8 | 2015 | 82 | |
| 9 | 2011 | 70 | |
| 10 | 2014 | 52 | |
| 11 | 2015 | 45 | |
| 12 | 2012 | 34 | |
| 13 | Maximizing the solubility advantage of amorphous pharmaceutical systems | 2010 | 1 |
About David E. Alonzo
David E. Alonzo is a scholar working on Pharmaceutical Science, Materials Chemistry, Analytical Chemistry, Spectroscopy and Food Science, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (10 papers), Crystallization and Solubility Studies (8 papers), Analytical Methods in Pharmaceuticals (3 papers), Analytical Chemistry and Chromatography (2 papers), Microencapsulation and Drying Processes (2 papers) and Protein purification and stability (1 paper). The work is most often cited by research in Pharmaceutical Science (1.5k citations), Analytical Chemistry (256 citations), Spectroscopy (337 citations), Materials Chemistry (929 citations) and Pharmacology (102 citations). David E. Alonzo has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Lynne S. Taylor, Yi Gao, Geoff G. Z. Zhang, Deliang Zhou, Shweta A. Raina, Tetsurou Handa, Huaping Mo, Nathaniel D. Catron, Bernard Van Eerdenbrugh and Donghua Zhu. Their work appears in journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Crystal Growth & Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.